Sign In
Or
Sign Up
Home
Distributor
Distributor
NovoProtein
百林科 BIO-LINK
广州市深裕生物科技有限公司
About Us
Contact Us
Language
EN
CONTACT US
Language
English
Back
Home
Distributor
About Us
Contact Us
EN
English
CONTACT US
Login
Back
NovoProtein
百林科 BIO-LINK
广州市深裕生物科技有限公司
EN
English
CONTACT US
Login
Search History
water
' OR 'x'='x
'
biotrend?Field[7]=***$3,222paymentavailable!Confirmyouroperationhere:http://protomed.org/?wh29au***hs=f8afeccd241c0ee5b48f4212f29c9c65*ххх*
PA106?Field[7]=*?Field[7]=* * * $3,222 credit available * * * hs=834a2f193f716e7cd4c5edb3a5db7662* ххх*'
You May Also Like
PA106?Field[7]=*
PA106
biotrend
PA106?Field[7]=* * * Get Free Bitcoin Now * * * hs=1906661d58550d60edb04cc06bfa5a71* ххх*
PA106?Field[7]=* * * $3,222 payment available! Confirm your transaction here: http://smartgreencourier.com/?4il9uc * * * hs=1906661d58550d60edb04cc06bfa5a71* ххх*
Sign In / Sign Up
Inquiry Cart
0
Home
Distributor
NovoProtein
百林科 BIO-LINK
广州市深裕生物科技有限公司
About Us
Contact Us
Search History
water
' OR 'x'='x
'
biotrend?Field[7]=***$3,222paymentavailable!Confirmyouroperationhere:http://protomed.org/?wh29au***hs=f8afeccd241c0ee5b48f4212f29c9c65*ххх*
PA106?Field[7]=*?Field[7]=* * * $3,222 credit available * * * hs=834a2f193f716e7cd4c5edb3a5db7662* ххх*'
You May Also Like
PA106?Field[7]=*
PA106
biotrend
PA106?Field[7]=* * * Get Free Bitcoin Now * * * hs=1906661d58550d60edb04cc06bfa5a71* ххх*
PA106?Field[7]=* * * $3,222 payment available! Confirm your transaction here: http://smartgreencourier.com/?4il9uc * * * hs=1906661d58550d60edb04cc06bfa5a71* ххх*
CONTACT US
0
Home
>
All Collections
>
DRA163 - Recombinant Influenza B (B/Yamagata/16/1988) HA Protein
DRA163 - Recombinant Influenza B (B/Yamagata/16/1988) HA Protein
No.DRA163
GET A QUOTE
Add to Quote List
View Quote List
facebook
line
twitter
whatsapp
pinterest
tumblr
linkedin
Description
Recombinant Influenza B (B/Yamagata/16/1988) HA Protein is produced by our Mammalian expression system and the target gene encoding Asp16-Tyr551 is expressed with a 6His tag at the C-terminus.
